New combo pill tackles two heart risks at once in late-stage trial
NCT ID NCT06165250
First seen Sep 30, 2025 · Last updated May 07, 2026 · Updated 32 times
Summary
This study tested whether taking two experimental drugs together (BR1018B and BR1018C) can safely lower both blood pressure and LDL cholesterol better than existing treatments. 156 adults with essential hypertension and primary hypercholesterolemia took part. The goal was to see if the combination works better than each drug alone after 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Keimyung University Dongsan Hospital
Daegu, South Korea
-
Seoul National University Boramae Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.